Table 1.
Characteristic | Incidence of pancreatic adenocarcinoma | Incidence of adenocarcinoma of the head of pancreas | Incidence of adenocarcinoma of the body and tail of pancreas | |||
---|---|---|---|---|---|---|
Cases, No (%)a | Rate (95% CI)b | Cases, No (%)a | Rate (95% CI)b | Cases, No (%)a | Rate (95% CI)b | |
Overall | 67,878 (100) | 6.95 (6.90 - 7.00) | 33,728 (100) | 3.46 (3.42 - 3.50) | 14,321 (100) | 1.46 (1.43 - 1.48) |
Sex | ||||||
Male | 35,062 (51.65) | 8.16 (8.07 - 8.24) | 17,033 (50.50) | 3.98 (3.92 - 4.04) | 7,666 (53.53) | 1.76 (1.72 - 1.81) |
Female | 32,816 (48.35) | 5.99 (5.93 - 6.06) | 16,695 (49.50) | 3.05 (3.00 - 3.09) | 6,655 (46.47) | 1.22 (1.19 - 1.25) |
Race | ||||||
White | 55,222 (81.35) | 6.77 (6.71 - 6.83) | 27,492 (81.51) | 3.37 (3.33 - 3.42) | 11,414 (79.70) | 1.40 (1.37 - 1.42) |
Black | 7,797 (11.49) | 9.85 (9.63 -10.08) | 3,961 (11.74) | 5.02 (4.86 - 5.19) | 1,727 (12.06) | 2.16 (2.05 - 2.27) |
Othersc | 4,755 (7.01) | 5.80 (5.63 - 5.97) | 2,229 (6.61) | 2.72 (2.61 - 2.84) | 1,153 (8.05) | 1.39 (1.31 - 1.48) |
Unknownd | 104 (0.15) | - | 46 (0.14) | - | 27 (0.19) | - |
Age at diagnosis, y | ||||||
<60 | 16,305 (24.02) | 1.93 (1.90 - 1.96) | 7,729 (22.92) | 0.92 (0.90- 0.94) | 3,750 (26.19) | 0.44 (0.43 - 0.46) |
>60 | 51,573 (75.98) | 32.28 (32.00 - 32.56) | 25,999 (77.08) | 16.30 (16.10 - 16.50) | 10,571 (73.81) | 6.58 (6.46 - 6.71) |
Statee | ||||||
California | 10,960 (16.15) | 7.06 (6.93 - 7.20) | 5,563 (16.49) | 3.60 (3.50 - 3.69) | 2,347 (16.39) | 1.50 (1.44-1.56) |
Connecticut | 10,906 (16.07) | 7.41 (7.27 - 7.55) | 5,363 (15.90) | 3.64 (3.54 - 3.74) | 2,306 (16.10) | 1.57 (1.51-1.63) |
Georgia | 5,113 (7.53) | 7.09 (6.89 - 7.29) | 2,585 (7.66) | 3.61 (3.46 - 3.75) | 1,178 (8.22) | 1.61 (1.52-1.71) |
Hawaii | 2,955 (4.35) | 6.47 (6.23 - 6.71) | 1,316 (3.90) | 2.88 (2.73 - 3.04) | 700 (4.89) | 1.53 (1.41-1.64) |
Iowa | 9,079 (13.38) | 6.75 (6.61 - 6.89) | 4,631 (13.73) | 3.42 (3.33 - 3.53) | 1,941 (13.55) | 1.46 (1.39-1.52) |
Michigan | 12,539 (18.47) | 7.87 (7.73 - 8.01) | 6,182 (18.33) | 3.89 (3.79 - 3.99) | 2,556 (17.85) | 1.60 (1.53-1.66) |
New Mexico | 3,890 (5.73) | 6.09 (5.89 - 6.28) | 1,928 (5.72) | 3.01 (2.87 - 3.15) | 671 (4.69) | 1.04 (0.96-1.12) |
Utah | 3,172 (04.67) | 5.32 (5.13 - 5.51) | 1,581 (4.69) | 2.67 (2.54 - 2.81) | 667 (4.66) | 1.11 (1.02-1.19) |
Washington | 9,264 (13.65) | 6.68 (6.55 - 6.82) | 4,579 (13.58) | 3.31 (3.22 - 3.41) | 1,955 (13.65) | 1.40 (1.34-1.47) |
Stage at diagnosisf | ||||||
Localized | 5,796 (8.54) | 0.60 (0.58 - 0.62) | 3,678 (10.90) | 0.38 (0.37 - 0.40) | 1,123 (7.84) | 0.11 (0.11 - 0.12) |
Regional | 18,623 (27.43) | 1.90 (1.88 - 1.93) | 13,193 (39.12) | 1.35 (1.33 - 1.37) | 2,140 (14.94) | 0.22 (0.21 - 0.23) |
Distant | 38,852 (57.24) | 3.96 (3.92 - 3.998) | 14,685 (43.54) | 1.50 (1.47 - 1.52) | 10,600 (74.02) | 1.08 (1.06 - 1.10) |
Unstaged | 4,607 (6.79) | 0.48 (0.47-0.50) | 2,172 (6.44) | 0.23 (0.22-0.24) | 458 (3.20) | 0.05 (0.04-0.05) |
aCases included first primary tumors that matched the selection criteria, were microscopically confirmed, and were not identified only from autopsy records
or death certificates
bRates were calculated as number of cases per 100,000 person-years and age adjusted to the 2000 US standard population
cIncludes American Indian/Alaskan Native and Asian/Pacific Islander
dRates for patients with unknown race could not be calculated, as ‘race’ is a population variable and must be known to calculate rates
eRates were calculated between 1973-2014 for all states except Georgia; 1975-2014, and Washington; 1974-2014
fUsing SEER historic stage A